• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动转运与玻璃体内注射脂质体的眼内分布。

Active Transport and Ocular Distribution of Intravitreally Injected Liposomes.

机构信息

Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

National Center for Nano Fabrication and Characterization, Technical University of Denmark, Lyngby, Denmark.

出版信息

Transl Vis Sci Technol. 2023 Aug 1;12(8):20. doi: 10.1167/tvst.12.8.20.

DOI:10.1167/tvst.12.8.20
PMID:37615641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10461645/
Abstract

PURPOSE

Drug delivery to the retina remains a challenge due to ocular barriers and fast clearing mechanisms. Nanocarrier drug delivery systems (NDDSs) hold the promise of prolonging intraocular retention times and increasing drug concentrations in the retina.

METHODS

Anionic and cationic PEGylated liposomes, loaded with oxaliplatin (OxPt) to be used as trace element, were prepared from dry lipid powders. The differently charged liposomes were intravitreally injected in C57BL/6JrJ mice; eyes were harvested 2 hours and 24 hours post-injection. To investigate active transport mechanisms in the eye, a subset of mice were pre-injected with chloroquine before injection with cationic liposomes. Eyes were dissected and the distribution of OxPt in different tissues were quantified by inductively coupled plasma mass spectrometry (ICP-MS).

RESULTS

Both liposome formulations enhanced the retention time of OxPt in the vitreous over free OxPt. Surprisingly, when formulated in cationic liposomes, OxPt translocated through the retina and accumulated in the RPE-sclera. Pre-injection with chloroquine inhibited the transport of liposomal OxPt from the vitreous to the RPE-sclera.

CONCLUSIONS

We show that liposomes can enhance the retention time of small molecular drugs in the vitreous and that active transport mechanisms are involved in the trans retinal transport of NDDS after intravitreal injections.

TRANSLATIONAL RELEVANCE

These results highlight the need for understanding the dynamics of ocular transport mechanisms in living eyes when designing NDDS with the back of the eye as the target. Active transport of nanocarriers through the retina will limit the drug concentration in the neuronal retina but might be exploited for targeting the RPE.

摘要

目的

由于眼部屏障和快速清除机制,药物向视网膜的输送仍然是一个挑战。纳米载体药物传递系统(NDDS)有望延长眼内滞留时间并增加视网膜中的药物浓度。

方法

从干燥的脂质粉末中制备载有奥沙利铂(OxPt)的阴离子和阳离子 PEG 化脂质体,用作微量元素。将不同带电的脂质体眼内注射到 C57BL/6JrJ 小鼠中;注射后 2 小时和 24 小时收获眼睛。为了研究眼睛中的主动转运机制,在注射阳离子脂质体之前,一部分小鼠预先注射了氯喹。通过电感耦合等离子体质谱法(ICP-MS)将眼睛解剖并定量分析 OxPt 在不同组织中的分布。

结果

两种脂质体配方均增强了玻璃体中 OxPt 的保留时间,超过了游离 OxPt。令人惊讶的是,当用阳离子脂质体配制时,OxPt 通过视网膜转运并在 RPE-脉络膜中积累。预先注射氯喹抑制了脂质体 OxPt 从玻璃体向 RPE-脉络膜的转运。

结论

我们表明脂质体可以增强玻璃体中小分子药物的保留时间,并且主动转运机制参与了眼内注射后 NDDS 的跨视网膜转运。

翻译的准确性和流畅性取决于多种因素,包括原文的清晰度、语法结构和词汇选择。如果你对译文有任何疑问或需要进一步的澄清,请随时提出。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/160e577024b8/tvst-12-8-20-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/dae36c3ddf57/tvst-12-8-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/d6d2b4cdd761/tvst-12-8-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/46d96982a851/tvst-12-8-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/160e577024b8/tvst-12-8-20-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/dae36c3ddf57/tvst-12-8-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/d6d2b4cdd761/tvst-12-8-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/46d96982a851/tvst-12-8-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/10461645/160e577024b8/tvst-12-8-20-f004.jpg

相似文献

1
Active Transport and Ocular Distribution of Intravitreally Injected Liposomes.主动转运与玻璃体内注射脂质体的眼内分布。
Transl Vis Sci Technol. 2023 Aug 1;12(8):20. doi: 10.1167/tvst.12.8.20.
2
Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin.纳米载体系统提高奥沙利铂的治疗效果。
Curr Cancer Drug Targets. 2022;22(5):361-372. doi: 10.2174/1568009622666220120115140.
3
Pharmacokinetics of Sirolimus in a Novel Liposome Delivery System in Selected Ocular Tissues and Plasma Following a Single Subconjunctival Injection in Dutch Belted Rabbits.新型脂质体给药系统中单剂玻璃体内注射后西罗莫司在选定眼组织和血浆中的药代动力学。
J Ocul Pharmacol Ther. 2022 Jul-Aug;38(6):424-432. doi: 10.1089/jop.2022.0030. Epub 2022 Jul 14.
4
Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes.通过玻璃体内注射包裹在脂质体中的血管活性肠肽下调内毒素诱导的葡萄膜炎。
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3230-8. doi: 10.1167/iovs.06-1305.
5
Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye.无晶状体玻璃体切除眼中玻璃体内脂质体的清除与定位
Invest Ophthalmol Vis Sci. 1987 May;28(5):907-11.
6
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.通过空间稳定脂质体进行寡核苷酸的玻璃体内递送。
Invest Ophthalmol Vis Sci. 2002 Jan;43(1):253-9.
7
Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.视网膜下注射AAV5载体后的基因治疗不受对侧眼先前玻璃体内注射AAV5载体的影响。
Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.
8
Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.单次玻璃体腔内注射贝伐西尼至兔眼后的眼内生物分布
Mol Vis. 2008 May 28;14:997-1005.
9
Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.阳离子脂质体包裹的紫杉醇靶向给药或阳离子脂质体包裹的维替泊芬靶向光动力疗法可减少脉络膜新生血管形成。
Mol Vis. 2013;19:54-61. Epub 2013 Jan 10.
10
Effect of eye pigmentation on transscleral drug delivery.眼色素沉着对经巩膜给药的影响。
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):333-41. doi: 10.1167/iovs.07-0214.

引用本文的文献

1
Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant.混合近红外响应脂质体/水凝胶平台介导视网膜母细胞瘤的化学-光热疗法,槲皮素作为佐剂可增强该疗法。
Theranostics. 2025 Mar 10;15(9):3995-4015. doi: 10.7150/thno.108471. eCollection 2025.

本文引用的文献

1
Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems.研究用于测试玻璃体内脂质体药物递送系统性能的离体动物模型。
Pharmaceutics. 2021 Jul 2;13(7):1013. doi: 10.3390/pharmaceutics13071013.
2
Stable Retinoid Analogue Targeted Dual pH-Sensitive Smart Lipid ECO/pDNA Nanoparticles for Specific Gene Delivery in the Retinal Pigment Epithelium.用于视网膜色素上皮细胞特异性基因递送的稳定类视黄醇类似物靶向双pH敏感智能脂质ECO/pDNA纳米颗粒
ACS Appl Bio Mater. 2020 May 18;3(5):3078-3086. doi: 10.1021/acsabm.0c00130. Epub 2020 Apr 3.
3
Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization.
脂质体和细胞外囊泡作为药物传递系统:组成、药代动力学和功能化的比较。
Adv Healthc Mater. 2022 Mar;11(5):e2100639. doi: 10.1002/adhm.202100639. Epub 2021 Jun 24.
4
Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface.眼内脂质体视网膜递药的眼部屏障:玻璃体视网膜界面的影响。
J Control Release. 2020 Dec 10;328:952-961. doi: 10.1016/j.jconrel.2020.10.028. Epub 2020 Oct 19.
5
Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes.兔眼玻璃体内注射抗体和纳米颗粒的眼内分布和动力学。
Transl Vis Sci Technol. 2020 May 20;9(6):20. doi: 10.1167/tvst.9.6.20. eCollection 2020 May.
6
Cell targeting strategy affects the intracellular trafficking of liposomes altering loaded doxorubicin release kinetics and efficacy in endothelial cells.细胞靶向策略会影响脂质体的细胞内转运,从而改变载药阿霉素的释放动力学和在血管内皮细胞中的疗效。
Int J Pharm. 2020 Oct 15;588:119715. doi: 10.1016/j.ijpharm.2020.119715. Epub 2020 Aug 1.
7
In Vivo Measurement of the Human Vitreous Chamber Volume Using Computed Tomography Imaging of 100 Eyes.应用 CT 成像对 100 只眼的人玻璃体腔容积进行活体测量。
Transl Vis Sci Technol. 2020 Jan 29;9(1):2. doi: 10.1167/tvst.9.1.2. eCollection 2020 Jan.
8
The evidence of SARS-CoV-2 infection on ocular surface.SARS-CoV-2 感染眼表的证据。
Ocul Surf. 2020 Jul;18(3):360-362. doi: 10.1016/j.jtos.2020.03.010. Epub 2020 Apr 11.
9
No flow through the vitreous humor: How strong is the evidence?玻璃体无液流:证据有多确凿?
Prog Retin Eye Res. 2020 Feb 6:100845. doi: 10.1016/j.preteyeres.2020.100845.
10
Intravitreal nanoparticles for retinal delivery.玻璃体腔递药纳米粒
Drug Discov Today. 2019 Aug;24(8):1510-1523. doi: 10.1016/j.drudis.2019.05.005. Epub 2019 May 16.